Tony Tremblay Selected Research

Infections

1/2022	Seroprevalence of SARS-CoV-2 antibodies among blood donors in Québec: an update from a serial cross-sectional study.
1/2021	High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samples.
10/2020	Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike.
7/2020	Cross-sectional evaluation of humoral responses against SARS-CoV-2 Spike.
10/2007	Picogram doses of lipopolysaccharide exacerbate antibody-mediated thrombocytopenia and reduce the therapeutic efficacy of intravenous immunoglobulin in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tony Tremblay Research Topics

Disease

5	Infections 01/2022 - 10/2007
4	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 02/2013 - 10/2004
3	COVID-19 01/2022 - 10/2020
3	Thrombocytopenia (Thrombopenia) 02/2013 - 10/2006
2	Autoimmune Diseases (Autoimmune Disease) 10/2006 - 10/2004
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Bacterial Infections (Bacterial Infection) 10/2007

Drug/Important Bio-Agent (IBA)

4	Intravenous Immunoglobulins (IVIG)FDA Link 02/2013 - 10/2004
3	VaccinesIBA 01/2022 - 10/2020
3	AntibodiesIBA 01/2022 - 10/2007
3	Inosine Triphosphate (ITP)IBA 02/2013 - 10/2004
2	Neutralizing AntibodiesIBA 10/2020 - 07/2020
2	Antigen-Antibody Complex (Immune Complex)IBA 02/2013 - 10/2006
2	Immunoglobulin G (IgG)IBA 02/2013 - 10/2006
1	COVID-19 VaccinesIBA 01/2022
1	ImmunosorbentsIBA 01/2022
1	EnzymesIBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	Therapeutic UsesIBA 02/2013
1	Interferon-gamma (Interferon, gamma)IBA 10/2007
1	LipopolysaccharidesIBA 10/2007
1	Monoclonal AntibodiesIBA 10/2006

Therapy/Procedure

1	Blood Component Removal (Apheresis) 01/2022
1	Therapeutics 01/2021